Alphatec price to free cash flow ATEC
Market value divided by free cash flow over the last twelve months, since 2016.
- Today, Nov 2, 2026
- 370×
- Peer median
- 16.9×
Alphatec's price to free cash flow is 370× as of Nov 2, 2026.
The median for 10 medical instruments and supplies stocks of a similar size is 16.9×.
Price to free cash flow over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 370× | 164× | 370× |
| 2025 | n/m a value too high to mean anything | ||
| 2024 | n/m a value too high to mean anything | ||
| 2023 | n/m a value too high to mean anything | ||
| 2022 | n/m a value too high to mean anything | ||
| 2021 | n/m a value too high to mean anything | ||
| 2020 | n/m a value too high to mean anything | ||
| 2019 | n/m a value too high to mean anything | ||
| 2018 | n/m a value too high to mean anything | ||
| 2017 | n/m a value too high to mean anything | ||
| 2016 | 100× | 61.9× | 247× |
Against its peers
Companies in Medical - Instruments & Supplies nearest Alphatec's size, closest first, today.
| Company | Price to free cash flow |
|---|---|
| ATECAlphatec | 370× |
| BVSBioventus | 11.7× |
| IARTIntegra Lifesciences | 12.3× |
| STAAStaar Surgical | n/m |
| IRMDIradimed | 38.9× |
| CDRECadre | 17.3× |
| EYENational Vision | 27.6× |
| MOVMovado | 10.0× |
| LMATLemaitre Vascular | 25.2× |
| INSPInspire Medical Systems | 16.6× |
| UFPTUFP Technologies | n/m |
| Peer median | 16.9× |
What the price to free cash flow tells you
Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.
Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.
More on Alphatec
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.